Federal grants to Abbratech Inc.
Abbratech Inc. in Branford, Connecticut received $8.5 million in federal grants from fiscal 2021 to 2025, across 8 awards. Its largest program was Biomedical Research and Research Training, with $7.0 million. In fiscal 2025 it was awarded $1.8 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$8.5 million
- Awards8
- Awarded in FY 2025$1.8 million
- Largest award$2.2 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $592,590 |
| FY 2023 | 4 | $2.8 million |
| FY 2024 | 4 | $3.4 million |
| FY 2025 | 2 | $1.8 million |
Programs that fund Abbratech Inc.
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 6 | $7.0 million |
| Allergy and Infectious Diseases Research | 2 | $1.5 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 8 | $8.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Method for the validation by western analysis of affinity reagents against post-translationally modified proteins. - abstract antibodies (ABS) are commonly employed in biomedical research to identify and quantify target proteins. However, the specificity, sensitivity and reliability of these abs can | Biomedical Research and Research Training | September 19, 2023 | $2.2 million |
| Platform for the high throughput generation and validation of affinity reagents - abstract we present a complete platform for the rapid generation and validation of recombinant mabs. The innovations of this proposal include: (1) the pathena vector system for overnight conversion of phage display scf | Biomedical Research and Research Training | January 26, 2023 | $2.2 million |
| Structure-guided neutralizing antibodies developed using epivolve technology - abstract current strategies for developing neutralizing abs are not effective and typically involve screening iggs from recovered patients. Pandemic viruses evolve for mutations that can shield their epitopes from host im | Allergy and Infectious Diseases Research | May 5, 2023 | $1.3 million |
| A platform for t-cell receptor mimic antibody generation modeled using phla-a*11:01 kras G12D - abstract this phase II proposal is an ambitious advancement for precision oncology, focusing on the discovery and validation of t cell receptor mimic antibodies (TCRMS) targeting mutation-associated neoan | Biomedical Research and Research Training | December 6, 2024 | $1.2 million |
| Directed discovery and validation of anti-splice-junction site abs - abstract this fast track proposal's overarching goal is to develop a comprehensive platform for the identification and validation of recombinant antibodies (ABS) that are specific to protein isoform splice-junction sites. This init | Biomedical Research and Research Training | September 20, 2024 | $757,299 |
| Method for the validation by western analysis of affinity reagents against post-translationally modified proteins. I. Survey of existing antibodies, and II. Development of method improvements - abstract the poor reproducibility of published research is a major focus of the scientific community in re | Biomedical Research and Research Training | March 23, 2022 | $338,149 |
| T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy - abstract current therapeutic antibodies target the cell surface and within the external cellular environment. Yet intracellular proteins make up half of the proteome. Having a facile means of targeting thos | Biomedical Research and Research Training | June 22, 2023 | $293,719 |
| Method for the isolation of antibodies with functional activity against cell surface targets - “method for the isolation of antibodies with functional activity against cell surface targets” abstract we have derived a method for isolating functional mabs against cell surface receptors that are separa | Allergy and Infectious Diseases Research | June 1, 2022 | $240,990 |
Questions people ask
How much federal grant money does Abbratech Inc. get?
$8.5 million in 8 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Abbratech Inc. the most?
The Department of Health and Human Services, with $8.5 million in 8 awards.
What is Abbratech Inc.'s largest federal grant?
$2.2 million under Biomedical Research and Research Training, with its first action in the period on September 19, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Abbratech Inc.?
Its largest are Biomedical Research and Research Training and Allergy and Infectious Diseases Research.
Other grant recipients in Branford
- Branford Board of Education
- Rnaconnect, Inc.
- Isoplexis Corporation
- Verinomics, Inc
- The Connecticut Hospice, Inc.
Largest federal grant recipients in Connecticut · Federal grants in Connecticut